biopharma exectuives

Biopharma Execs Weigh Controversial Move: Opting Out of Medicare to Escape Drug Price Negotiations
BioSpace
Wed, 06/21/23 - 10:39 am
Inflation Reduction Act
PhRMA
biopharma exectuives
Medicare
drug pricing